TI
tru Independence Portfolio holdings
AUM
$346M
This Quarter Return
+8.29%
1 Year Return
+13.72%
3 Year Return
+42.26%
5 Year Return
+64.25%
10 Year Return
–
AUM
$695M
AUM Growth
–
Cap. Flow
+$695M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
22.88%
Holding
959
New
958
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$49.3M |
| 2 |
Microsoft
MSFT
|
$14.3M |
| 3 |
AT&T
T
|
$12.8M |
| 4 |
Apple
AAPL
|
$12.6M |
| 5 |
Kroger
KR
|
$12.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 16.84% |
| 2 | Technology | 10.24% |
| 3 | Industrials | 8.77% |
| 4 | Financials | 8.56% |
| 5 | Consumer Discretionary | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $49.3M | 7.09% | +1,081,698 | New | +$49.3M |
|
|
2
Microsoft
MSFT
$3.77T
| $14.3M | 2.05% | +90,451 | New | +$14.3M |
|
|
3
AT&T
T
$209B
| $12.8M | 1.85% | +378,005 | New | +$12.8M |
|
|
4
Apple
AAPL
$3.45T
| $12.6M | 1.81% | +46,959 | New | +$12.6M |
|
|
5
Kroger
KR
$44.9B
| $12.1M | 1.75% | +412,788 | New | +$12.1M |
|
6
JPMorgan Chase
JPM
$829B
| $11.9M | 1.71% | +106,932 | New | +$11.9M |
|
7
General Motors
GM
$55.8B
| $11.8M | 1.7% | +409,855 | New | +$11.8M |
|
8
Intel
INTC
$107B
| $11.7M | 1.69% | +204,615 | New | +$11.7M |
|
9
Pfizer
PFE
$141B
| $11.7M | 1.68% | +334,186 | New | +$11.7M |
|
10
Corning
GLW
$57.4B
| $10.8M | 1.56% | +435,102 | New | +$10.8M |
|
11
LyondellBasell Industries
LYB
$18.1B
| $10.5M | 1.51% | +145,160 | New | +$10.5M |
|
12
Gilead Sciences
GILD
$140B
| $10.1M | 1.46% | +135,656 | New | +$10.1M |
|
|
WRK
13
DELISTED
WestRock Company
WRK
| $9.62M | 1.38% | +269,025 | New | +$9.62M |
|
14
Merck
MRK
$210B
| $9.6M | 1.38% | +85,318 | New | +$9.6M |
|
15
United Parcel Service
UPS
$74.1B
| $9.4M | 1.35% | +89,973 | New | +$9.4M |
|
16
General Mills
GIS
$26.4B
| $9.25M | 1.33% | +173,970 | New | +$9.25M |
|
17
Johnson & Johnson
JNJ
$427B
| $9.07M | 1.3% | +65,613 | New | +$9.07M |
|
18
BP
BP
$90.8B
| $8.97M | 1.29% | +294,309 | New | +$8.97M |
|
19
CVS Health
CVS
$92.8B
| $8.92M | 1.28% | +126,963 | New | +$8.92M |
|
20
Weyerhaeuser
WY
$18.7B
| $8.87M | 1.28% | +380,230 | New | +$8.87M |
|
21
Bank of America
BAC
$376B
| $8.78M | 1.26% | +265,699 | New | +$8.78M |
|
22
SPDR S&P Biotech ETF
XBI
$5.07B
| $8.77M | 1.26% | +113,184 | New | +$8.77M |
|
23
iShares Biotechnology ETF
IBB
$5.6B
| $8.61M | 1.24% | +79,883 | New | +$8.61M |
|
24
ATI
ATI
$10.7B
| $8.49M | 1.22% | +466,030 | New | +$8.49M |
|
|
RDS.B
25
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $8.25M | 1.19% | +178,090 | New | +$8.25M |
|